Burkitt lymphoma (BL) is a highly aggressive, rapidly growing B cell non-Hodgkin
lymphoma, which manifests in several subtypes including sporadic, endemic, and …

Early identification of ultra-risk diffuse large B-cell lymphoma (DLBCL) patients is needed to
aid stratification to innovative treatment. Previous studies suggested high baseline total …

Mucosa-associated lymphoid tissue (MALT) lymphoma involves the mucosa-associated
lymphoid tissue potentially arising from any mucosal site, with the stomach as the most …

Background: 18-fluorodeoxyglucose positron emission tomography/computed tomography
(18 F-PET/CT) has been widely applied for the imaging of head and neck squamous cell …

Introduction: Our aim was to evaluate the performance in clinical research and in clinical
routine of a research prototype, called positron emission tomography (PET) Assisted …

Objective Mantle cell lymphoma (MCL) is an aggressive lymphoma sub-type with poor
prognosis and high 18F-FDG avidity at PET/CT; nowadays, no validated criteria for PET/CT …

Elderly Hodgkin lymphoma (HL) is an aggressive lymphoma subgroup with high 18F-FDG
avidity at 18F-FDG-PET/CT but no shared criteria for PET/CT in treatment evaluation and …

There is a lack of markers for predicting favorable outcomes after pembrolizumab therapy in
patients with non-small cell lung cancer (NSCLC) with programmed death ligand-1 (PD-L1) …

Mucosa‐associated lymphoid tissue (MALT) lymphoma is an indolent lymphoma with good
prognosis and variable fluorine‐18 fluorodeoxyglucose (18F‐FDG) avidity. Many possible …

Purpose In the present study, we aimed to investigate the role of baseline, interim and end-
of treatment positron emission tomography/computed tomography (PET/CT) in assessing the …